Literature DB >> 28421878

Cerebrovascular injury in cryptococcal meningitis.

Ajay Kumar Mishra1, Vanjare Harshad Arvind1, Divya Muliyil1, Cijoy K Kuriakose1, Anu Anna George1, Reka Karuppusami1, Ronald Albert Benton Carey1, Sunithi Mani1, Samuel George Hansdak1.   

Abstract

Background Cryptococcal meningitis continues to be one of the common causes of chronic central nervous system infection worldwide. Individuals with cryptococcal meningitis can occasionally present with small vessel vasculitis causing infarcts primarily in the basal ganglia, internal capsule, and thalamus. Literature regarding patterns of cerebrovascular injury among patients with cryptococcal meningitis is scanty, and outcome following these vascular involvements is unknown. Aim To study the clinical profile, imaging findings, and details of vascular territory involved among patients admitted with cryptococcal meningitis and central nervous system infarct in a tertiary care center from India. And to compare the outcomes of patients of cryptococcal meningitis with or without central nervous system infarcts in terms of mortality and morbidity, Methodology A total of 151 patients with microbiologically proven cryptococcal meningitis over a time span of 11 years were retrospectively enrolled into the study. Of these, 66 patients met the inclusion criteria of having appropriate imaging of the brain. The presence of infarct in the imaging was analyzed by two independent radiologists. Patterns of central nervous system involvement and types of vascular injury were ascertained based on radiological parameters. Clinical parameters and outcomes of patients with and without infarcts were compared. Results Twenty (13%) of these patients had evidence of central nervous system infarcts on imaging. The mean age of patients with and without infarcts was 41 years and 38 years, respectively. Male predominance was present among both the groups. The presence of fever, neck stiffness, positive blood culture, and hydrocephalus in central nervous system imaging was similar among patients with or without infarct. Longer duration of illness, low sensorium at the time of presentation, low Glasgow Coma Scale score, presence of meningeal inflammation, cryptococcomas, and basal exudates in imaging were higher in patients with infarct. All the infarcts were of the lacunar type. Sixty percent of the cerebrovascular infarcts were acute in nature, 50% of these being multiple. Unilateral infarcts were seen in 70% of the patients. The most common site of infarct was the basal ganglia, others being distributed over the thalamus, frontal, temporal, parieto-occipital regions in the descending order. The presence of neurovascular involvement in the form of infarcts to the risk of morbidity and mortality had an odds ratio of 9.1 and 2.6, respectively. Conclusion Neurovascular involvement in chronic cryptococcal meningitis is a rare entity. These tend to present as multiple lacunar infarcts. Mortality and morbidity associated with these patients is higher when compared to patients who do not have infarcts. This result suggests that vascular injury plays a role in predicting outcome of patients with cryptococcal meningitis. Future studies are needed to understand the mechanism by which vascular events (infarcts) occur and result in poor outcome.

Entities:  

Keywords:  Chronic disease; cerebral infarction; ischemic stroke; radiology; risk factors; vasculitis

Mesh:

Year:  2017        PMID: 28421878     DOI: 10.1177/1747493017706240

Source DB:  PubMed          Journal:  Int J Stroke        ISSN: 1747-4930            Impact factor:   5.266


  9 in total

1.  Deceptively asymptomatic cryptococcaemia in a renal transplant recipient: the lull before a storm.

Authors:  Vivek Sood; Navin Pattanashetti; Raja Ramachandran; Krishan Lal Gupta
Journal:  BMJ Case Rep       Date:  2019-04-20

Review 2.  Thrombolytic Agents: Nanocarriers in Controlled Release.

Authors:  Soodabeh Hassanpour; Han-Jun Kim; Arezoo Saadati; Peyton Tebon; Chengbin Xue; Floor W van den Dolder; Jai Thakor; Behzad Baradaran; Jafar Mosafer; Amir Baghbanzadeh; Natan Roberto de Barros; Mahmoud Hashemzaei; Kang Ju Lee; Junmin Lee; Shiming Zhang; Wujin Sun; Hyun-Jong Cho; Samad Ahadian; Nureddin Ashammakhi; Mehmet R Dokmeci; Ahad Mokhtarzadeh; Ali Khademhosseini
Journal:  Small       Date:  2020-08-12       Impact factor: 13.281

Review 3.  Central Nervous System Infections in Immunocompromised Patients.

Authors:  Amy A Pruitt
Journal:  Curr Neurol Neurosci Rep       Date:  2021-05-26       Impact factor: 5.081

4.  Case Report: Cryptococcal meningitis in an apparently immunocompetent patient in Nepal - challenges in diagnosis and treatment.

Authors:  Ashish Jha; Sudeep Adhikari; Keshav Raj Sigdel; Buddhi Paudyal; Buddha Basnyat; Gyan Kayastha; Sumita Pradhan; Ujjwol Risal; Jiwan Poudel
Journal:  Wellcome Open Res       Date:  2019-06-17

5.  Cryptococcosis Presenting as Cerebrovascular Disease.

Authors:  Bedirhan Tarhan; Yusuf Mehkri; Justin De Prey; Calvin Hu; Ibrahim S Tuna; Hans Shuhaiber
Journal:  Cureus       Date:  2021-11-10

6.  Blood vessel occlusion by Cryptococcus neoformans is a mechanism for haemorrhagic dissemination of infection.

Authors:  Josie F Gibson; Aleksandra Bojarczuk; Robert J Evans; Alfred Alinafe Kamuyango; Richard Hotham; Anne K Lagendijk; Benjamin M Hogan; Philip W Ingham; Stephen A Renshaw; Simon A Johnston
Journal:  PLoS Pathog       Date:  2022-04-21       Impact factor: 7.464

7.  Neurocognitive outcomes of tuberculous meningitis in a primarily HIV-positive Ugandan cohort.

Authors:  Carson M Quinn; John Kasibante; Alice Namudde; Ananta S Bangdiwala; Mable Kabahubya; Noeline Nakasujja; Sarah Lofgren; Alison Elliott; David R Boulware; David B Meya; Fiona V Cresswell
Journal:  Wellcome Open Res       Date:  2022-03-03

8.  Central Nervous System Vasculitis for Cryptococcosis in an Immunocompetent Patient.

Authors:  Dan Zimelewicz Oberman; Liliana Patrucco; Carolina Cuello Oderiz
Journal:  Diseases       Date:  2018-08-31

9.  Cryptococcal meningitis mimicking cerebral infarction: a case report.

Authors:  Weihua Zhou; Jianbo Lai; Tingting Huang; Yi Xu; Shaohua Hu
Journal:  Clin Interv Aging       Date:  2018-10-12       Impact factor: 4.458

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.